Sale!

TTBK2 Gene Spinocerebellar Ataxia Type 11 Autosomal Dominant Genetic Test

Original price was: $700.Current price is: $500.

-29%

The TTBK2 Gene Spinocerebellar Ataxia Type 11 Autosomal Dominant NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the TTBK2 gene responsible for spinocerebellar ataxia type 11 (SCA11). This comprehensive genetic analysis utilizes next-generation sequencing technology to detect autosomal dominant inheritance patterns associated with progressive neurological disorders affecting coordination and movement. The test provides crucial information for individuals experiencing symptoms like gait instability, tremors, and speech difficulties, enabling early intervention and personalized treatment planning. Available for $500 USD, this advanced genetic screening offers peace of mind through accurate diagnosis and comprehensive genetic counseling services.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

TTBK2 Gene Spinocerebellar Ataxia Type 11 Autosomal Dominant NGS Genetic DNA Test

Understanding TTBK2 Gene Spinocerebellar Ataxia Type 11

Spinocerebellar ataxia type 11 (SCA11) represents a rare hereditary neurological disorder characterized by progressive degeneration of the cerebellum and spinal cord. This autosomal dominant condition results from mutations in the TTBK2 gene, which plays a crucial role in neuronal function and development. The TTBK2 Gene Spinocerebellar Ataxia Type 11 Autosomal Dominant NGS Genetic DNA Test provides comprehensive analysis using advanced next-generation sequencing technology to identify specific genetic variations responsible for this debilitating condition.

What This Test Measures and Detects

Our advanced genetic testing specifically targets:

  • Comprehensive sequencing of the TTBK2 gene for pathogenic mutations
  • Detection of autosomal dominant inheritance patterns
  • Identification of specific genetic variants associated with SCA11
  • Analysis of gene expression and protein function impacts
  • Assessment of mutation severity and clinical implications

Who Should Consider This Test

This genetic test is recommended for individuals experiencing:

  • Progressive gait instability and coordination difficulties
  • Uncontrollable tremors and involuntary movements
  • Speech abnormalities and dysarthria
  • Family history of neurological disorders
  • Early-onset cerebellar symptoms
  • Unexplained balance and coordination problems
  • Progressive difficulty with fine motor skills

Clinical Benefits of Genetic Testing

Undergoing the TTBK2 Gene Spinocerebellar Ataxia Type 11 test provides numerous advantages:

  • Accurate diagnosis and confirmation of SCA11
  • Early intervention and treatment planning
  • Family planning and genetic counseling opportunities
  • Personalized management strategies
  • Improved understanding of disease progression
  • Access to specialized neurological care
  • Peace of mind through definitive diagnosis

Test Specifications and Process

Technical Details

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Testing Method: Next-Generation Sequencing (NGS) Technology
  • Specialty: Neurology and Genetics
  • Disease Category: Neurological Disorders

Pre-Test Requirements

Before testing, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session with our specialists
  • Development of detailed family pedigree chart
  • Discussion of testing implications and expectations
  • Informed consent process completion

Understanding Your Test Results

Our comprehensive genetic analysis provides clear, actionable results:

  • Positive Result: Indicates presence of TTBK2 gene mutation associated with SCA11
  • Negative Result: No detected mutations in the TTBK2 gene
  • Variant of Uncertain Significance: Requires further clinical correlation
  • Carrier Status: Important for family planning considerations

All results include detailed interpretation by our board-certified genetic specialists and recommendations for next steps in management and care.

Test Pricing Information

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, Charlotte, San Francisco, Indianapolis, Seattle, Denver, Washington DC, Boston, El Paso, Nashville, Detroit, Oklahoma City, Portland, Las Vegas, Memphis, Louisville, Baltimore, and Milwaukee.

Take Control of Your Neurological Health

Don’t let uncertainty about neurological symptoms affect your quality of life. Our TTBK2 Gene Spinocerebellar Ataxia Type 11 Autosomal Dominant NGS Genetic DNA Test provides the clarity and answers you need for informed healthcare decisions. With advanced NGS technology and expert genetic analysis, we deliver accurate results you can trust.

Ready to take the next step? Book your test today or call our genetic specialists at +1(267) 388-9828 for personalized consultation and scheduling.

Our dedicated team is available to answer your questions, provide detailed information about the testing process, and help you understand how genetic testing can benefit your neurological health journey.